All In Biotech

Drug Trial Radar · NCT06952634

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

A Phase 1, Open Label, Single Dose Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of ESK001

Last checked: Nov 19, 2026Latest source record: May 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Apr 29, 2025

Primary completion

Mar 24, 2026

Study completion Mar 24, 2026

Sponsor

Lead sponsor
Alumis IncIndustry
Sponsor type
Industry
First posted
May 1, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This a phase 1, open label, single dose, parallel cohort study to determine the pharmacokinetics (PK) of study drug (ESK-001) in healthy volunteer participants, and participants with mild, moderate, and severe hepatic impairment.

Conditions

  • Hepatic Impairment

Interventions

  • envudeucitinibDrug

    Single oral dose of ESK-001 in participants from all cohorts

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax)Time frame: 48 hours
  2. Area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration [AUC(0-T)]Time frame: 48 hours
  3. Area under the plasma concentration-time curve from time zero extrapolated to infinite time [AUC(INF)]Time frame: 48 hours

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Orange County Research Center

    Lake Forest, California

  • Panax Clinical Research

    Miami Lakes, Florida

  • Orlando Clinical Research Center

    Orlando, Florida

  • Alliance for Multispecialty Research

    Knoxville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.